Netflix: A Good Company, But A Terribly Overpriced Stock [View article]
Mark Muhaney jumped in and upgraded NFLX today.$210 then $300 so he agrees with you. But stock is flat today. Icahn will take profits from $90 buys. Stock could go to $200 but no MO MO.
Netflix: A Good Company, But A Terribly Overpriced Stock [View article]
Netflix is a cult stock with the moniker of "disruptive business model". I have not used the service but at $8 compared to cable tiers it definitely has value. But to say because it launched one movie,"House of Cards ", it is another Time Warner, HBO or AMC is ridiculous. How many movies can you watch from FIOS cable selections? Maybe over 100 good ones. Netflix still needs to generate new content. The market cap of AMCX is $4B, HBO is valued at $13B, TNT is valued at $10B and the NFLX market cap $10.6B. How will Netflix beat these long standing experienced content companies? The buzz on Netflix was created by Icahn and major funds and they eventually need to take profits.
Is Biotech Getting Too Frothy? Investor Sentiment Suggests Irrational Exuberance [View article]
Good article Stephen. I agree the sector is frothy and although the industry is more mature in terms of products, revenues and strong clinical data we have to remember the risk. However it is hard to buy protection on gains and way too soon to short anything. And the 4th Quarter is usually good for biotech. The institutions are buying biotech stocks in a big way so I cannot see any major sell-off until Q1 2013.
Emerging Biomarker Diagnostics: BGMedicine And Vermillion [View article]
This will be an interesting year for both companies beginning with Q1 results, however I do not expect any breakthrough news until we see the angle of the sales ramp. VRML has more trading volume because of the retail interest, whereas BGMD has a large institutional insider holdings.
Clinical Data Rising: Is a Buyout Imminent? [View article]
Fidelity owns 4.4M shares highly unusual for a speculative Company at this stage. They are the #1 Institutional investor. I have not looked at where these positions are distributed among their mutual funds or maybe Fidelity is a venture investor. Also interesting is the history of how this Company evolved like the recent sale of the genomics piece.
There are a lot of people on this site that have an opinion or interest in SQNM. But other than a nice chart what does this article say? When we see the name Najarian we expect a lot more. Like was this a stealth "sell" recommendation because of the red bars? What about the SQNM options? Does the "option Monster track them?
Financial Sector Ultra-Shorts: Must Have Protection Against Banking Sector Madness [View article]
SRS Ultra Short Real Estate is only for "extreme traders" who like volatility of 5-10% per day. Do a search and you'll see that it is a very controversial ETF that does not track real estate equities and in fact may actually affect the very REITS they are supposed to track! Before trading SRS read the prospectus and read this:
The most excellent "Zero Hedge" Web site has done your REIT homework for you... zerohedge.blogspot.com...
Record High Crude: Free Markets Meet the Cartel [View article]
Investors and Traders buy into energy sector Gold back on track with oil, gold up $11 to end at $882; dollar is weak as ECB holds rates steady
The new alliance of energy rich countries such as Russia, VZ, Iran,SA et al combined with global investors in driving the upward momentum of the energy trade. Iran fed the bull as oil minister Nozari said that $200 oil is not far away due to dollar weakness.
Skeptics say it is speculation driving prices but even large pension funds such as CALPERS have significant positions in commodities especially oil, otherwise their returns for 2008 would be dismal. Momentum begets momentum. After a brief correction last week energy stocks are on the go with most subsectors up 2-4% such as bellwether XLE up 2% to a new high touching 85:
Integrateds: COP CVX HES up ~2% Services: FSESX SLB WFT XES up ~3.5% Nat Gas: CHK DVN FSNGX SJT XTO up 1-2%,SWN up 3.2%. Royalty trusts were mixed as PGH and PBR were flat and BBEP was up ~2%.
Refiners are still spooked by crude action and SUN TSO VLO all took hits so a bottom for these stocks is not at hand. However MRO was up 1.6%. Analytical types in the industry who study fundamental data are obviously missing the bigger picture.
On Tuesday Arjun Murti of Goldman Sachs raised oil targets from $120 to the $150-200 range for the next 6-24 mos. Murti also said demand for middle distillates such as diesel, heating oil and jet fuel are racing up signaling tightness in global refining capacity.
Politicians rather than be seen as aloof and clueless suggested a moratorium on summer federal gas taxes offering a paltry $80 saving for the average driver. And the immediate effect of lower rates seems to be raising oil prices.
Positions: diversified equal weighting in energy service nat gas and integrateds. New position last week-- NE. Adding to core positions on weakness. Waiting for entry on refiners but not now.
AMAG Pharmaceuticals Worth Far Less - Merrill [View article]
AMAG had a bullet proof business model but it was based upon milestone assumptions one year later.In the meantime the entire former management team bailed at the top~$65/sh. Now the FDA and launch milestone dates are here and the Co. cant deliver. See Yahoo chat on competitition.In the meantime hedgies who moved the stock up from 30 to 70 are getting out.
Alkermes Still Not Getting Full Credit For Its Pipeline [View article]
Is There No End To The Biotech Bull Market? [View article]
Netflix: A Good Company, But A Terribly Overpriced Stock [View article]
Netflix: A Good Company, But A Terribly Overpriced Stock [View article]
Netflix: A Good Company, But A Terribly Overpriced Stock [View article]
Is Biotech Getting Too Frothy? Investor Sentiment Suggests Irrational Exuberance [View article]
Biotech ETFs In Focus: XBI Vs. IBB [View article]
Emerging Biomarker Diagnostics: BGMedicine And Vermillion [View article]
Clinical Data Rising: Is a Buyout Imminent? [View article]
Sequenom Plunges on Earnings Miss [View article]
Financial Sector Ultra-Shorts: Must Have Protection Against Banking Sector Madness [View article]
The most excellent "Zero Hedge" Web site has done your REIT homework for you...
zerohedge.blogspot.com...
The Anatomy of Spending and Business in Biotech [View article]
Record High Crude: Free Markets Meet the Cartel [View article]
Gold back on track with oil, gold up $11 to end at $882; dollar is weak as ECB holds rates steady
The new alliance of energy rich countries such as Russia, VZ, Iran,SA et al combined with global investors in driving
the upward momentum of the energy trade. Iran fed the bull as oil minister Nozari said that $200 oil is not far away due to dollar weakness.
Skeptics say it is speculation driving prices but even large pension funds such as CALPERS have significant positions in commodities
especially oil, otherwise their returns for 2008 would be dismal. Momentum begets momentum. After a brief correction last week energy
stocks are on the go with most subsectors up 2-4% such as bellwether XLE up 2% to a new high touching 85:
Integrateds: COP CVX HES up ~2%
Services: FSESX SLB WFT XES up ~3.5%
Nat Gas: CHK DVN FSNGX SJT XTO up 1-2%,SWN up 3.2%.
Royalty trusts were mixed as PGH and PBR were flat and BBEP was up ~2%.
Refiners are still spooked by crude action and SUN TSO VLO all took hits so a bottom for these stocks is not at hand. However MRO was up 1.6%.
Analytical types in the industry who study fundamental data
are obviously missing the bigger picture.
On Tuesday Arjun Murti of Goldman Sachs raised oil targets from $120 to the $150-200 range for the next 6-24 mos.
Murti also said demand for middle distillates such as diesel, heating oil and jet fuel are racing up signaling tightness in global refining capacity.
Politicians rather than be seen as aloof and clueless suggested a moratorium on summer federal gas taxes offering a paltry $80 saving for
the average driver. And the immediate effect of lower rates seems to be raising oil prices.
Vikram Saxena sums it up well:
seekingalpha.com/artic...
Positions: diversified equal weighting in energy service nat gas and integrateds. New position last week-- NE.
Adding to core positions on weakness. Waiting for entry on refiners but not now.
Time for Biotech To Turn Around? [View article]
BBH does not get rebalanced
AMAG Pharmaceuticals Worth Far Less - Merrill [View article]